|
Volumn 253, Issue 1 SUPPL., 2006, Pages
|
Botulinum toxin in patients with multiple sclerosis
|
Author keywords
Botulinum toxin; Multiple sclerosis; Spasticity; Treatment
|
Indexed keywords
BACLOFEN;
BOTULINUM TOXIN;
IMMUNOMODULATING AGENT;
INTERFERON;
SPASMOLYTIC AGENT;
STEROID;
TRIAMCINOLONE;
CLINICAL FEATURE;
CONFERENCE PAPER;
DISABILITY;
DISEASE COURSE;
DRUG EFFICACY;
DRUG SAFETY;
HUMAN;
MULTIPLE SCLEROSIS;
PATHOGENESIS;
PRIORITY JOURNAL;
QUALITY OF LIFE;
SPASTICITY;
TREATMENT FAILURE;
BOTULINUM TOXIN TYPE A;
HUMANS;
MULTIPLE SCLEROSIS;
NEUROMUSCULAR AGENTS;
SPASM;
|
EID: 32544434255
PISSN: 03405354
EISSN: None
Source Type: Journal
DOI: 10.1007/s00415-006-1106-y Document Type: Conference Paper |
Times cited : (23)
|
References (0)
|